Myriad Genetics
Myriad Genetics, Inc. is a molecular diagnostics and precision medicine company committed to advancing health and well-being for all. It develops and commercializes molecular tests that help patients and providers uncover genetic insights. The company was founded by Walter A. Gilbert, Mark H. Skolnick, and Peter D. Meldrum in May 1991 and is headquartered in Salt Lake City, UT.
What If You Bought MYGN Earlier?
Estimate based on split history only. Excludes dividends, fees, taxes, and intraday movement.
Stock Split History
Newest split first. Cumulative multiple = compounded growth from that date to today.
| Split Date | Price Before | Ratio | Split Multiple | Cumulative |
|---|---|---|---|---|
| Mar 26, 2009 | $44.54 | 2-for-1 | 2× | 4× |
| Sep 12, 2000 | $31.75 | 2-for-1 | 2× | 2× |
Myriad Genetics Market Cap Timeline
Validated annual market-cap history is available from 1996. Split markers cover all 2 recorded splits. Filled dots have market-cap data for that year; hollow dots mark split years outside market-cap source coverage.